discontinued

AR10570PU-L Hepatitis C Virus Core Genotype 6a (2-119)

Search for all "Hepatitis C Virus Core Genotype 6a"

Vue générale rapide

Hepatitis C Virus Core Genotype 6a

AR10570PU-L

Description du Produit Hepatitis C Virus Core Genotype 6a

Hepatitis C Virus Core Genotype 6a.
Presentation: Purified

Caractéristiques du Produit Hepatitis C Virus Core Genotype 6a

Type de Produit Proteins & Growth Factors
Quantité 1 mg
Presentation Purified
Source E. coli
Destination Worldwide
Fiche Technique Télécharger la fiche technique
Fournisseur Acris Antibodies GmbH
Material Safety DataSheet (MSDS) MSDS for Proteins (de)

Extrait de la Fiche Technique

Pureté Protein is >95% pure as determined by 10% PAGE (coomassie staining).
Purification Method: Sepharose-Derived Purification.
Applications Antigen in ELISA and Western blots, excellent antigen for detection of HCV with minimal specificity problems.
Sujet HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae.
HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6). 
Concentration 1.0 mg/ml
Stockage

Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Description
Description:
The E.coli derived recombinant protein contains the HCV nucleocapsid immunodominant regions, amino acids 2-119. 
Specificity: Immunoreactive with sera of HCV- infected individuals.
Presentation
Buffer:
25mM Tris-HCl, 1mM EDTA, 1,5M Urea, 50% Glycerol
Pureté:
Protein is >95% pure as determined by 10% PAGE (coomassie staining).
Purification Method: Sepharose-Derived Purification.
Format:
Purified
  • LinkedIn